Customer Center
Login | Register

LEADERSHIP

Leadership Team

Our leadership team brings decades of diverse experience and a history of success in the medical device, life science and in vitro diagnostics markets

EXECUTIVE OFFICERS

MANAGEMENT TEAM

BOARD OF DIRECTORS

EXECUTIVE OFFICERS

Nachum “Homi” Shamir

President and Chief Executive Officer

Mr. Shamir joined Luminex Corporation in October, 2014. Mr. Shamir previously served, from 2006 to 2014, as President and CEO of Given Imaging, a developer, manufacturer, and marketer of diagnostic products for the visualization and detection of disorders of the gastrointestinal tract. Prior to joining Given Imaging, Mr. Shamir was Corporate Vice President of Eastman Kodak Company and President of Eastman Kodak´s Transaction and Industrial Solutions Group. Additionally, he served over 10 years at Scitex Corporation in positions of increasing responsibility, including President and CEO from 2003 to 2004. Prior to Scitex Corporation, Mr. Shamir held senior management positions at various international companies mainly in the Asia Pacific regions. Mr. Shamir currently serves on the board of directors of Invendo Medical GmbH. Mr. Shamir holds a Bachelor of Science from the Hebrew University of Jerusalem and a Masters of Public Administration from Harvard University.

Harriss T. Currie

Chief Financial Officer, Senior Vice President, Finance and Treasurer

Mr. Currie was elected as the VP, Finance, Treasurer and Chief Financial Officer in October of 2003. Since joining the company in November of 1998, Mr. Currie served in the capacities of Controller, Treasurer and Acting Chief Financial Officer. Prior to joining Luminex, he was employed as the Chief Financial Officer, Secretary and Treasurer of SpectraCell Laboratories from 1993 to 1998 where he also served as Vice President of Finance for two subsidiary companies. Mr. Currie earned his B.B.A. from Southwestern University in 1986 and his M.B.A. in Finance and Marketing from The University of Texas at Austin in 1992. Prior to returning to school for his M.B.A., Mr. Currie was a certified public accountant with Deloitte & Touche LLP.

Todd C. Bennett

Senior Vice President, Global Sales and Customer Operations

Mr. Bennett joined Luminex in October of 2012 as General Manager, Americas. He was promoted to Vice President, Global Sales and Customer Operations in July, 2015 and to Senior Vice President, Global Sales and Customer Operations in November of 2016. From January 2007 through March 2012, he was the Vice President of Sales and then promoted to the Vice President of Commercial Operations at Immucor, Inc. where he was responsible for Commercial Operations (Sales, Global Marketing, Customer Service functions). Prior to Immucor, he held various commercial leadership roles at Roche Diagnostics and Abbott Laboratories dating to 1994. Mr. Bennett holds a B.S. in Business Administration with an emphasis in finance from the Max M. Fisher College of Business at The Ohio State University in Columbus, Ohio.

Charles J. Collins, Ph.D.

Vice President, Systems Research and Development

Dr. Collins joined Luminex Corporation in 2006 and was named Vice President of Systems Research and Development in May 2012. During his tenure Dr. Collins has held increasing leadership positions most recently as Senior Director of the Advanced Technology Group. As a recognized expert with over 35 publications in the field of engineering, Dr. Collins led the successful development of the MAGPIX instrument. Prior to joining Luminex, Dr. Collins conducted research at the University of Texas at Austin and the U.S. Army Research Laboratory. Dr. Collins earned his Ph.D. in solid state electronics from the University of Texas at Austin.

Nancy M. Fairchild, SPHR

Senior Vice President, Human Resources

Mrs. Fairchild joined Luminex in March of 2010 as the Senior Director of Human Resources and was promoted to Vice President, Human Resources in August 2012. She previously served as Chief Administrative Officer and Vice President of Human Resources and Organizational Development for the Electric Reliability Council of Texas (ERCOT). Prior to ERCOT, Mrs. Fairchild served as Vice President Human Resources for Esoterix, Inc., an international healthcare company specializing in laboratory services. Mrs. Fairchild is currently a member of the Board of Directors for Workforce Solutions, representing the biotech sector. She graduated with honors from Texas State University with a B.S. degree in Math Education and a Master’s degree in Counseling.

Scott C. Johnson, Ph.D.

Vice President, Assay Research & Development

Dr. Johnson was named Vice President of Product Development & Manufacturing of our Madison, WI site following the acquisition of EraGen Biosciences in June of 2011. During his nearly 10 years with EraGen, he held leadership roles of increasing responsibility, most recently as Vice President of Product Development. Dr. Johnson’s responsibilities include leadership of the MultiCode®-RTx Technology and family of products. Prior to EraGen Biosciences, Dr. Johnson served in a senior technical role with CHIMERx and the USDA-National Animal Disease Center. Dr. Johnson earned a Ph.D. in Cellular and Molecular Biology at the University of Wisconsin-Madison in 1997.

Tadd S. Lazarus, M.D.

Senior Vice President and Chief Medical Officer

Dr. Tadd Lazarus became our Senior Vice President and Chief Medical Officer in October, 2016. Dr. Lazarus has responsibility for Medical Affairs, Regulatory Affairs, Reimbursement, as well as Health and Public Policy. Dr. Lazarus came to Luminex from QIAGEN, where he served as Chief Medical Officer and Head of Medical & Scientific Affairs, Reimbursement and Public Policy from 2013 to 2016. Dr. Lazarus previously served as Chief Medical Officer and Vice President, Clinical Affairs at Gen-Probe from 2010 to 2012. Dr. Lazarus’ background covers many facets of the in-vitro diagnostic industry including immunochemistry, clinical chemistry, point-of-care, molecular diagnostics and next-generation sequencing. Before joining the industry in 1998, Dr. Lazarus served as Medical Director of HIV Ambulatory Care Programs at the former St. Vincent’s Hospital and Medical Center in New York City. Dr. Lazarus holds a B.S. in Biology and Physiology from Marlboro College, an M.D. from Ross University School of Medicine, and has completed postgraduate training in Internal Medicine at Englewood Hospital and Medical Center in Englewood, NJ.

Randall “Randy” Myers

Senior Vice President, Global Manufacturing and Quality

Prior to joining the Company, Mr. Myers accepted an early retirement from Applied Materials in 2012 and has been consulting in supply chain and manufacturing operations since that time. Prior to his retirement, Mr. Myers held various positions at Applied Materials in manufacturing and operations from 1995-2012. In his final position with Applied Materials, Mr. Myers was Vice President with the Silicon Systems Group (SSG) Global Planning & Business Operations. Prior to joining Applied Materials, Mr. Myers worked at General Electric Aircraft Engines in Cincinnati, Ohio in various areas of procurement, supply chain and engineering from 1986-1995. Mr Myers attended Kettering University where he obtained a B.S. in Electrical Engineering.

Richard Rew

Senior Vice President, Legal, General Counsel, and Corporate Secretary

Prior to joining the Company, Mr. Rew served as Senior Vice President, Legal, General Counsel, and Secretary at ArthroCare Corporation from December 2008 until they were acquired by Smith & Nephew in 2014. Mr. Rew joined ArthroCare in 2006 as its Vice President, Legal Affairs. Mr. Rew previously served as General Counsel of Activant Solutions Inc. from 2000-2006 and as General Counsel of EZCORP, Inc. from 1996-2000. Mr. Rew earned a B.A. from the Plan II honors program at the University of Texas at Austin and a J.D from the University of Oklahoma College of Law. Mr. Rew is a Member of the State Bar of Texas.

Eric S. Shapiro

Vice President, Global Marketing

Mr. Shapiro joined Luminex Corporation in October 2015 and currently serves as Vice President, Global Marketing. In this capacity, Mr. Shapiro has responsibility for all Global Marketing efforts, including Strategic, Product, Scientific, Brand, Web, and Digital. He is also responsible for Trade Shows, Events, and Marketing Communications. Prior to joining Luminex Corporation on a full-time basis, Mr. Shapiro worked with Luminex on a consulting basis as a General Manager for the Market Launch of ARIES® and NxTAG® RPP. Mr. Shapiro has previously served as a Vice President of Marketing for Given Imaging, and held numerous leadership positions at Kinetic Concepts, Inc., including Vice President of Marketing, Vice President of Patient Administration, Director of Corporate Development, and Director of Mergers and Acquisitions. Mr. Shapiro began his career working in both office and hospital-based Sales positions with Merrell Dow and Marion Merrell Dow. Mr. Shapiro holds a B.S. degree from Syracuse University, with an emphasis in Marketing and Telecommunications Management, and an M.B.A. from the J.L. Kellogg Graduate School of Management, with an emphasis in Marketing, Healthcare, Organizational Behavior, and Economics.

 

Back to top

MANAGEMENT TEAM

Steven Back

Vice President, Global Quality Assurance

Mr. Back joined Luminex Corporation as Vice President of Manufacturing in June of 2008. Prior to joining Luminex, Mr. Back was employed for 18 years at Abbott Laboratories Diagnostic Division in Dallas. While at Abbott, he held various management and technical positions in Manufacturing Operations, Technical Product Development and Quality. Prior to joining Abbott Laboratories, he was a Test Development Engineer for General Dynamics in Ft. Worth Texas. Mr. Back graduated from Wright State University in 1984 with a B.S. degree in Systems Engineering and holds an M.S.E.E degree from the University of Texas at Arlington as well as a M.B.A. from the University of Dallas.

David Bourne

Vice President, Business Development and Strategic Planning

Mr. Bourne was appointed Vice President, Business Development and Strategic Planning in January, 2015. Previously, he held roles of increasing responsibility within the Business Development function, most recently as Senior Director. Mr. Bourne joined Tm Bioscience in July 2006, which became Luminex Molecular Diagnostics following the acquisition of Tm Bioscience by Luminex in March 2007. Prior to joining Tm, he worked at Merck KGaA and Bayer in a variety of business development, sales management and general management roles. Mr. Bourne earned a B.Sc. in Chemistry from McMaster University.

Thomas J. Copa

Vice President, Partner Development

Mr. Copa was appointed Vice President, Technology and Strategic Partnerships in October, 2012. Since joining Luminex in October, 2001, Mr. Copa has served as Director of Strategic Partner Development, Senior Director, Research Sales and Marketing, Business Unit Manager, Luminex Ag Science, and most recently as the Vice President, Luminex Life Sciences. Prior to joining Luminex, Mr. Copa was employed by Cardinal Health. While at Cardinal Health he held various positions in sales and sales management. Mr. Copa earned a B.A. from the College of Arts and Sciences, Marquette University.

Ronald D. Dunn

Vice President, Global Regulatory and Clinical Affairs

Mr. Dunn’s industry background includes over 25 years’ experience and demonstrated performance excellence in the in-vitro diagnostics, biotechnology and pharmaceutical industries. He joined Luminex in June 2011 as Senior Director, Quality and Regulatory Affairs following the acquisition of EraGen Biosciences where he held the role VP Quality, Regulatory and Clinical Affairs. Previous to EraGen, Mr. Dunn held the role of Director, Global Quality and Regulatory at Regulatory Compliance Associates where he delivered value to corporations by creating world-class quality systems using a risk-based approach to compliance and achieved successful regulatory submissions through working collaboratively with national and international regulatory agencies. Prior to Regulatory Compliance Associates, he held increasing roles of responsibility at Life Technologies, Third Wave Technologies and Genzyme Corporation. Mr. Dunn holds a B.A. degree in Microbiology and Chemistry with an emphasis in Laboratory Technology from Lakeland College and has taken various executive management and organizational behavior courses throughout his career.

Andrew D. Ewing

Vice President, Customer Experience

Mr. Ewing joined Luminex Corporation in May 2005 and currently serves as Vice President, Customer Experience. During his tenure, Mr. Ewing has held the positions of Vice President, Partner and Operations Development and Vice President, Technical Operations. Prior to joining Luminex Corporation, Mr. Ewing held management and business leadership roles as Senior Director, Customer Relations at ClearOrbit, Inc., Senior Manager of Sustaining Application Services at Dell Inc., Director of Global Support Services for 724 Solutions Inc., and Director of Operations at SCC Communications Corporation (Intrado Inc.).

Kendel B. Martin, CPA

Vice President, Accounting

Mrs. Martin joined Luminex Corporation in December 2007 and currently serves as Vice President, Accounting. In this capacity, Mrs. Martin has responsibility for Finance and Accounting, Financial Planning and Analysis and Facilities. Previously at Luminex Corporation, Mrs. Martin held the position of Executive Director, Finance and Accounting and Director of Financial Reporting. Prior to joining Luminex Corporation, Mrs. Martin held management roles as External Reporting Manager at Freescale Semiconductor, Internal Audit Manager at Cirrus Logic and Audit Senior Manager at Ernst & Young LLP. Mrs. Martin holds a B.A. in Economics from Rhodes College and is a Texas Certified Public Accountant.

BOARD OF DIRECTORS

Nachum “Homi” Shamir

President and Chief Executive Officer
Executive Committee
Strategy & Development Committee

Mr. Shamir joined Luminex Corporation in October, 2014. Mr. Shamir previously served, from 2006 to 2014, as President and CEO of Given Imaging, a developer, manufacturer, and marketer of diagnostic products for the visualization and detection of disorders of the gastrointestinal tract. Prior to joining Given Imaging, Mr. Shamir was Corporate Vice President of Eastman Kodak Company and President of Eastman Kodak´s Transaction and Industrial Solutions Group. Additionally, he served over 10 years at Scitex Corporation in positions of increasing responsibility, including President and CEO from 2003 to 2004. Prior to Scitex Corporation, Mr. Shamir held senior management positions at various international companies mainly in the Asia Pacific regions. Mr. Shamir currently serves on the board of directors of Invendo Medical GmbH. Mr. Shamir holds a Bachelor of Science from the Hebrew University of Jerusalem and a Masters of Public Administration from Harvard University.

G. Walter Loewenbaum

Chairman of the Board
Executive Committee

Mr. Loewenbaum has served as a member of the board of directors since May 1995 and as Chairman of the board of directors since September 2002. Mr. Loewenbaum also has served as chairman of the board of directors of 3D Systems since September 1999, and was previously chairman of the board of directors of Envoy. He holds a B.A. from the University of North Carolina.

 

Mr. Loewenbaum originally became involved with Luminex as an original investor in Luminex prior to our initial public offering. As an investment banker and private equity investor, Mr. Loewenbaum has worked with multiple companies in a variety of different industries at different phases of organizational development, ranging from startup to publicly traded. He brings depth of knowledge in serving as chairman for public and private companies, building stockholder value and capital market considerations. Mr. Loewenbaum also brings continuity to the board of directors, given his service on the board since Luminex’s earliest years of operation.

Robert J. Cresci

Chairman of the Nominating and Corporate Governance Committee
Audit Committee

Mr. Cresci has served as a member of the board of directors since December 1996. He has been a Managing Director of Pecks Management Partners Ltd., an investment management firm, since September 1990. Mr. Cresci currently serves on the boards of directors of j2 Global Communications, Inc., a provider of outsourced, value-added messaging and communications services and OFS Capital Corporation, a business development company. Within the past five years, Mr. Cresci has served on the board of directors of Sepracor Inc., a research-based pharmaceutical company, and SeraCare Life Sciences, Inc, a provider of a broad scope of biological products and services. Mr. Cresci holds an undergraduate degree in Engineering from the United States Military Academy at West Point and holds a M.B.A. in Finance from the Columbia University Graduate School of Business.

 

Mr. Cresci originally became involved with Luminex as an early investor in Luminex. Mr. Cresci has extensive experience serving on the boards of directors of private and public companies within the broader healthcare industry and brings a significant depth of knowledge in capital markets considerations. Mr. Cresci’s knowledge of the operations of public company boards is particularly useful in his current role as chairman of the Nominating and Corporate Governance Committee. Mr. Cresci also brings continuity to the board of directors, given his service on the board since Luminex’s earliest years of operation. 

Stephen L. Eck, M.D., Ph.D

Strategy & Development Committee

Stephen L. Eck, MD, PhD, age 61, joined the board of directors in March 2016. Since 2011 he has served as the Vice President, Oncology Medical Sciences of Astellas Pharma Global Development, a global pharmaceutical company. He is responsible for the design and conduct of domestic and international oncology clinical studies, which include the use of molecular testing for disease diagnosis and to monitor drug efficacy and safety.

 

From 2007 to 2011, Dr. Eck served as Vice President, Translational Medicine & Pharmacogenomics at Eli Lilly, a global pharmaceutical company. There, he was responsible for the clinical pharmacology components of drug development, including both early phase clinical studies and late stage drug development studies. He was responsible for the Diagnostic and Experimental Medicines and laboratory for Experimental Medicine departments which designed, built and deployed novel clinical test platforms to be used in clinical studies. Before his tenure at Eli Lily, Dr. Eck led drug development teams at Pfizer from 2002 to 2007, including the Molecular Profiling Group and the Translational Medicine organization.

 

Prior to joining the pharmaceutic industry, Dr. Eck was a member of the faculty of the University of Pennsylvania School of Medicine, where he focused on Hematology and Oncology. He is a Fellow of the American Association for the Advancement of Science. He also serves on the Scientific Advisory Board of the ACGT Foundation, the Board of Trustees of the Keck Graduate Institute, the Board of Directors of the Central Pennsylvania Clinic, and on the Board of Directors of the Personalized Medicine Coalition. Dr. Eck holds a B.S. in Chemistry from Kalamazoo College, a Ph.D. in Chemistry from Harvard University and a M.D. in Medicine from the University of Mississippi.

Thomas W. Erickson

Chairman of the Executive Committee

Mr. Erickson has served as a member of the board of directors since May 2004. Mr. Erickson served as our Interim President and Chief Executive Officer from September 2002 until our hiring of Mr. Balthrop in May 2004. He is currently chairman of the board of Western Dental Services, Inc., a dental practice management company, and Inmar, Inc., a reverse logistics and revenue recovery company. Previously, he served as a Senior Advisor to New Mountain Capital, LLC, a private equity firm, chairman and interim president of National Medical Health Card Systems, Inc., a pharmacy benefits manager, chairman of the board of PATHCare, Inc., an operator of long term care facilities, chairman of the board of TransHealthcare, Inc., a health care services company, chairman and interim president and chief executive officer of LifeCare Holdings, Inc., an operator of long-term acute care hospitals, and interim president and chief executive officer and director of Omega Healthcare Investors, Inc., a healthcare focused real estate investment trust. Mr. Erickson was also co-founder, president and chief executive officer of CareSelect Group, Inc., a physician practice management company. Earlier in his career, he held several management positions at American Hospital Supply Corporation. Mr. Erickson currently serves on the board of directors of American Renal Associates, a national provider of kidney dialysis services. Mr. Erickson holds a Bachelors degree from University of Iowa and an M.B.A. from Southern Methodist University.

 

Mr. Erickson brings to the board of directors extensive experience managing and growing healthcare industry companies, as well as significant general experience serving in leadership roles on boards and board committees of other public companies. Through his experience serving as Luminex’s Interim President and Chief Executive Officer from September 2002 until May 2004, Mr. Erickson offers to the board detailed insight into the Company’s business and management considerations. Through his substantial experience in the healthcare industry, in particular healthcare services and delivery, Mr. Erickson offers valuable insight on Luminex and its product offerings from the perspective of healthcare providers.

Fred C. Goad, Jr.

Compensation Committee
Nominating and Corporate Governance Committee

Mr. Goad has served as a member of the board of directors since September 1997. Since August 2001, he has been a member in Voyent Partners, L.L.C. (“Voyent”), a private investment company. Mr. Goad served as co-chief executive officer of the transaction services division of WebMD Corporation (“WebMD”), a provider of healthcare transaction, information and technology services, from June 2000 through March 2001. From March 1999 through May 2000, Mr. Goad served as senior advisor to the office of the president of the transaction services division of Quintiles Transnational Corporation (“Quintiles”), a contract research company providing a wide range of clinical research services for biotech and pharmaceutical clients. Mr. Goad served as co-chief executive officer and chairman of Envoy from June 1996 until Envoy was acquired by Quintiles in March 1999. From 1985 to June 1996, Mr. Goad served as president and chief executive officer of Envoy Corporation (“Envoy”), a provider of electronic transaction processing services for the healthcare industry. Within the past five years, Mr. Goad has served on the board of directors of Emageon Inc., a provider of information technology systems for hospitals, healthcare networks and imaging facilities, until its sale in 2008, Performance Food Group Company, a foodservice distributor, and on the boards of directors of several private companies. Mr. Goad holds a B.S. in business from the University of Virginia.

 

Mr. Goad brings to the board of directors extensive experience managing and growing healthcare industry companies, as well as significant general experience serving on boards of other public companies. Through his vast experience in the healthcare industry, in particular healthcare services and delivery, Mr. Goad offers valuable insights on Luminex and its product offerings and sales and marketing strategies from the perspective of healthcare providers. Mr. Goad also brings continuity to the board of directors, given his service on the board since Luminex’s earliest years of operation.

Jay B. Johnston

Chairman of Compensation Committee
Strategy & Development Committee

Mr. Johnston has served as a member of the board of directors since February 2005. Mr. Johnston currently serves as chairman of QuesTek Innovations, LLC, a privately-held company that designs and markets high tech materials, a position he has held since August 2001. From 1975-1999, he held numerous positions at Abbott Laboratories, a global, broad-based health care company (“Abbott”), most recently as corporate vice president for diagnostic assays and systems. He held numerous other positions with Abbott, including president of Dainabot Co. Ltd. and vice president Asia Pacific. Mr. Johnston has experience in general management, product development, technology management, strategic marketing and business development. He holds an M.B.A. in General Management from the Amos Tuck School of Business Administration and a B.A. degree in Public Administration from Dartmouth College.

 

Mr. Johnston brings to the board of directors significant directly relevant industry experience in managing businesses in the diagnostics and life sciences industries. Mr. Johnston has extensive experience in leading the strategic and operational aspects of large complex, international organizations. Mr. Johnston’s knowledge of effective compensation processes for management helps him to guide the Company’s compensation programs and policies in his role as Chair of the Compensation Committee. Mr. Johnston also offers particular experience and perspective to the board of directors in the areas of product development and marketing strategies through his role on the Strategy and Development Committee.

Jim D. Kever

Compensation Committee

Mr. Kever has served as a member of the board of directors since December 1996. He has been a member in Voyent since August 2001. Mr. Kever served as co-chief executive officer of the transaction services division of WebMD from June 2000 to March 2001. From March 1999 through May 2000, Mr. Kever served as chief executive officer of the transaction services division of Quintiles. From August 1995 through March 1999, Mr. Kever was the president and co-chief executive officer of Envoy. Mr. Kever serves on the boards of directors 3D Systems Corporation (“3D Systems”), a provider of 3-D printing, rapid prototyping and manufacturing solutions, and Tyson Foods, Inc., a food production company (“Tyson”). Within the past five years, Mr. Kever has served on the board of directors of ACI Worldwide, Inc., a global provider of electronic payments solutions for financial institutions. Mr. Kever holds a B.S. in business administration from the University of Arkansas and a J.D. from the Vanderbilt University School of Law.

 

Mr. Kever brings to the board of directors extensive experience managing and growing healthcare industry companies. Mr. Kever brings experience in serving on public and private boards. Mr. Kever, through his more recent investment experiences with Voyent, also brings depth of knowledge in managing and growing companies and in capital markets considerations. Mr. Kever also brings continuity to the board of directors, given his service on the board since Luminex’s earliest years of operation.

Kevin M. McNamara

Chairman of the Audit Committee

Mr. McNamara has served as a member of the board of directors since May 2003. In addition, he provided financial and strategic consulting services to the Company from October 2001 through December 2002. Mr. McNamara served as executive vice president, chief financial officer and treasurer of HealthSpring, Inc., a managed care company, from April 2005 through May 2009. Mr. McNamara also served as non-executive chairman from April 2005 through January 2006 of MedAvant Healthcare Solutions (f/k/a ProxyMed, Inc.), a provider of automated healthcare business and cost containment solutions for financial, administrative and clinical transactions in the healthcare payments marketplace, and served as interim chief executive officer and as a director of ProxyMed, Inc. from December 2004 through June 2005. Mr. McNamara previously served as chief financial officer of HCCA International, Inc., a healthcare management and recruitment company from October 2002 to April 2005. Mr. McNamara currently serves on the board of directors of Tyson Foods, Inc., a food processing company. Within the past five years, Mr. McNamara has served on the board of directors of COMSYS IT Partners, Inc. (f/k/a Personnel Group of America, Inc.), an information technology staffing and solutions provider. Mr. McNamara is a Certified Public Accountant (inactive) and holds a B.S. in Accounting from Virginia Commonwealth University and a M.B.A. from the University of Richmond.

 

Mr. McNamara brings to the board of directors extensive financial expertise, experience managing and growing healthcare industry companies, as well as significant general experience serving on boards and board committees of other public companies. Mr. McNamara’s experience overseeing risk assessment, accounting and financial reporting for public and other healthcare companies provides equally valuable experience in his role as chair of our Audit Committee. Mr. McNamara also has experience overseeing public and private capital markets and mergers and acquisitions transactions.

Edward A. Ogunro, Ph.D

Chairman of the Strategy & Development Committee
Nominating and Corporate Governance Committee
Audit Committee
Executive Committee

Dr. Ogunro has served as a member of our board of directors since May 2009. Dr. Ogunro served as senior vice president, R&D and medical affairs and chief scientific officer at Hospira Inc., a global specialty pharmaceutical and medication delivery company, from April 2004 until December 2007. Prior to Abbott’s spin-off of Hospira in 2004, Dr. Ogunro served in a number of leadership positions for over 20 years with Abbott, primarily in Abbott’s Diagnostics Division, and most recently served as corporate vice president, R&D, medical and regulatory affairs in Abbott’s Hospital Products Division. He held numerous other positions with Abbott, including program director for AxSym, one of the most successful analyzers in the diagnostic industry, and divisional vice president for Abbott’s Immunodiagnostics and Chemistry R&D Organization. Dr. Ogunro currently serves on the board of directors of the Myeloproliferative Neoplasms Research Foundation (a not for profit organization.) Dr. Ogunro served on the board of directors of Applied NeuroSolutions, Inc., a company focused on the development of an integrated portfolio of products for the treatment and diagnosis of Alzheimer’s disease. Previously, Dr. Ogunro pursued postdoctoral studies and served as an assistant professor at Northwestern University Medical School in Chicago from 1977 to 1982. Dr. Ogunro holds a B.S. in Physiology and Biochemistry from Reading University and a Ph.D. in Biochemistry from London University.

 

Dr. Ogunro brings to the board of directors significant directly relevant technical and operational industry experience in the diagnostics and medical device industry. Dr. Ogunro has substantial experience in managing complex research and development initiatives for large, evolving portfolios of diagnostic and medical device products, and in securing and maintaining regulatory clearance for such products both domestically and internationally. Dr. Ogunro’s technical background and direct experience with project management is of particular relevance in his role on the Strategy and Development Committee and in guiding Luminex in its research and development investments on new products and markets.

 

Back to top